Variants in the transforming growth factor β (TGF-β) superfamily signaling pathways have been reported in a wide range of diseases, including cardiovascular diseases, skeletal abnormalities, connective tissue diseases and different types of cancer [49]. This evidence concerns the gene TGFB1 and cardiovascular disorder.